Enlivex Therapeutics Ltd.
General ticker "ENLV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $24.4M (TTM average)
Enlivex Therapeutics Ltd. follows the US Stock Market performance with the rate: 9.6%.
Estimated limits based on current volatility of 3.2%: low 1.12$, high 1.20$
Factors to consider:
- Total employees count: 11 as of 2014
- Price in estimated range
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.75$, 2.42$]
- 2025-12-31 to 2026-12-31 estimated range: [0.80$, 2.47$]
Financial Metrics affecting the ENLV estimates:
- Positive: with PPE of -1.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -52.71 <= 0.01
- Positive: Interest expense per share per price, % of 0.05 <= 0.73
- Positive: Investing cash flow per share per price, % of 36.71 > -0.63
- Positive: Shareholder equity ratio, % of 85.20 > 64.29
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ENLV quotes
Long-term ENLV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $29.39MM | $15.54MM |
| Operating Income | $-29.39MM | $-15.54MM |
| Non-Operating Income | $0.33MM | $0.52MM |
| Interest Expense | $0.01MM | $0.01MM |
| R&D Expense | $19.23MM | $10.13MM |
| Income(Loss) | $-29.07MM | $-15.01MM |
| Profit(Loss)* | $-29.07MM | $-15.01MM |
| Stockholders Equity | $30.08MM | $23.59MM |
| Assets | $36.83MM | $27.69MM |
| Operating Cash Flow | $-23.52MM | $-13.01MM |
| Capital expenditure | $0.24MM | $0.10MM |
| Investing Cash Flow | $-25.97MM | $9.06MM |
| Financing Cash Flow | $0.36MM | $6.45MM |
| Earnings Per Share** | $-1.56 | $-0.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.